CLINICAL DIAGNOSTICS AUTOMATION - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Million by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 62 companies including many key and niche players such as Abaxis, Inc., Abbott Diagnostics, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Diagnostica Stago, HORIBA ABX S.A.S., Hudson Robotics, Inc., Ortho Clinical Diagnostics, Inc., QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., Sysmex America, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc., and Vital Scientific B.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Code : MCP-6034
Price : $4800
Companies : 62
Pages : 539
Date : April 2011
Market Data Tables : 167

Complimentary Report Insights:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2  
   Data Interpretation & Reporting Level.......3
Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
  
   Market Segmentation.......4
Automated Analyzers.......4
Stand-Alone Automation.......4
Total Laboratory Automation.......4
  
   Clinical Diagnostics Automation: A Global Insight.......5
Regional Analysis.......5
US Leads the Clinical Diagnostics Automation Market.......5
1$100
   Analysis by Segment.......6
Automated Analyzers Remain in the Lead, Stand-Alone Automation to Drive Future Growth.......6
The Road Ahead for Clinical Diagnostics Automation.......6
1$100
   Growth Drivers in Lab Automation Market – A Snapshot.......7
Major Trends in Laboratory Automation Market.......7
1$100
   Major Issues and Challenges in the Industry.......81$100
   Automation – A Panacea to the Laboratories’ Plight.......9
End-User and Technology-Led Aspects Drive Demand for Automation.......9
Automation – The Prime Solution to Enhance Laboratory Efficiency.......9
1$100
   Total Laboratory Automation – Only Good Enough for Large Hospitals.......10
Large Hospitals See Good Returns to their Investments on TLA.......10
Issues Continue to Plague Large Scale Automation Solutions.......10
1$100
   Modular Automation Surges Ahead of TLA in Adoption.......11
Demand for POC Testing Rises.......11
1$100
   POC Analyzers Looming Central Labs.......12
POC Testing – Drivers and Challenges.......12
Recession Halts Momentum in Lab Automation Market.......12
1$100
   Regulatory Environment.......131$100
   Laboratory Automation: Order of the Day.......14
Benefits of Laboratory Automation.......14
Introduction to Clinical Diagnostics Automation.......14
1$100
   Evolution of Clinical Diagnostics Automation.......15
Components of Laboratory Automation System.......15
1$100
   Typical Diagnostic Laboratory Structure.......16
Laboratory Control and Information System.......16
Sample Storage.......16
1$100
   Sample Preparation.......17
Transportation.......17
Analysis.......17
Clinical Diagnostics Automation by Market Segment.......17
Automated Analyzers.......17
Stand-Alone Automation.......17
1$100
   Total Laboratory Automation (TLA).......18
Limitations of TLA Systems.......18
Modular Automation: Emerging Alternative.......18
1$100
   Total Laboratory Automation (TLA) Vs. Modular Laboratory Automation.......19
Decentralized Testing Gains Importance.......19
Advantages of POC Testing Over Centralized Laboratory Testing.......19
1$100
   Cost Analysis of POC Testing Vs. Laboratory Testing.......20
Cost Savings through Space Savings.......20
Major Components of Multi-Step Automation Process.......20
Consolidation of Workstation.......20
1$100
   Information Management.......211$100
   Sysmex to Unveil Cell Image Analysis Portfolio.......22
BD Introduces Innova™ and InocuLAB Platforms.......22
1$100
   HORIBA Medical Introduces Pentra C200 Compact Chemistry Analyzer.......23
Biocare Medical Introduces Automated Slide Stainer.......23
1$100
   Roche Unveils Cobas 4800 System.......24
Siemens Introduces VersaCell™ and other Lab Automation Systems.......24
1$100
   Sysmex America to Launch Sysmex TS-2000 Tube Sorter.......25
Randox Introduces Semi-Automated Analyzer.......25
QIAGEN Expands Diagnostic Instruments Portfolio.......25
Roche Receives CE Mark Certification for Cobas 8000 Modular Analyzer.......25
1$100
   IDH to Launch Products for Automated Diagnostic Analyzer.......26
Caliper Unveils Automated Ensemble and Reprise Systems.......26
1$100
   bioMérieux to Launch Full Microbiology Laboratory Automation Solutions.......27
Magellan and Subsidiaries to Roll Out Automated Systems and Diagnostic Assays.......27
1$100
   Transasia Bio-Medicals Unveils Automated Chemistry Analyzer.......28
Tecan Develops Cavro Omni Robot.......28
Abbott to Showcase ARCHITECT® ci4100TM Integrated System.......28
Horiba Unveils Two Laboratory Automation Systems.......28
1$100
   Siemens Healthcare Diagnostics Launches MicroScan WalkAway plus Systems.......29
Luminex to Introduce Innovative Bead-based Multiplexing Solution.......29
1$100
   Roche Acquires PVT Probenverteiltechnik to Expand Clinical Diagnostics Automation Portfolio.......30
Tecan Inks Global Manufacture and Supply Agreement with Enigma.......30
bioMérieux Inks Product Co-development and Marketing Agreement with Philips.......30
1$100
   NEXUS Snaps Up REMP from Tecan Group.......31
STRATEC Acquires US-based Ballista.......31
1$100
   Sysmex America and Amerinet Ink Hematology Contract Agreement.......32
IRIS’ Body Fluids Module Obtains FDA Clearance for Synovial Fluid Analysis.......32
IRIS International Acquires Bench-Top Instrument Platform from BioMicro spSystems.......32
1$100
   Sysmex Canada and EORLA Ink Capital Equipment and Vendor Supply Service Agreements.......33
Thermo Fisher Scientific to Acquire B-R-A-H-M-S Holding.......33
1$100
   Beckman Coulter Takes over Olympus’ Diagnostic Business.......34
Tecan and Hologic Ink OEM Agreement.......34
BD Takes Over HandyLab.......34
Pievesestina-Located Clinical Lab Selects FlexLab Automation System.......34
1$100
   Hudson Control Group Adopts Original Name.......35
Abbott Obtains FDA Approval for PRISM HIV O Plus Test.......35
Ortho Clinical Establishes Remote Monitoring Center in France.......35
1$100
   bioMerieux UK Bags Contract from The Royal Wolverhampton Hospitals NHS Trust.......36
Bio-Reference and Sysmex America Enter Sole Source Agreement.......36
Sysmex America Receives Approval from US FDA.......36
1$100
   Roche to Take Over Ventana Medical Systems.......37
Johnson & Johnson Nordic Takes Over Amic.......37
Bio-Rad Inks Joint Marketing Agreement with Siemens Medical Solutions.......37
1$100
   Siemens Medical Solutions Diagnostics Extends Agreement with Sysmex America.......38
RFCL Snaps Up Wipro BioMed.......38
Siemens Medical Solutions Acquired Dade Behring.......38
1$100
   Abaxis, Inc. (USA).......39
Abbott Diagnostics (US).......39
Beckman Coulter, Inc. (US).......39
1$100
   Becton, Dickinson and Company (US).......40
bioMérieux SA (France).......40
1$100
   Bio-Rad Laboratories, Inc. (US).......41
Caliper Life Sciences, Inc. (US).......41
Diagnostica Stago (France).......41
1$100
   HORIBA ABX S.A.S. (France).......42
Hudson Robotics, Inc. (US).......42
Ortho Clinical Diagnostics, Inc. (US).......42
QIAGEN (US).......42
1$100
   Roche Diagnostics (US).......43
Siemens Healthcare Diagnostics, Inc. (US).......43
1$100
   Sysmex America, Inc. (US).......44
Tecan Group Ltd. (Switzerland).......44
Thermo Fisher Scientific, Inc. (US).......44
1$100
   Vital Scientific B.V. (The Netherlands).......451$100
   Table 1: World Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......461$350
   Table 2: World Historic Review for Clinical Diagnostics Automation by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......471$350
   Table 3: World 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).......481$350
   Table 4: World Recent Past, Current and Future Analysis for Automated Analyzers by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......491$350
   Table 5: World Historic Review for Automated Analyzers by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......501$350
   Table 6: World 15-Year Perspective for Automated Analyzers by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).......511$350
   Table 7: World Recent Past, Current and Future Analysis for Stand-alone Automation by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......521$350
   Table 8: World Historic Review for Stand-alone Automation by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......531$350
   Table 9: World 15-Year Perspective for Stand-alone Automation by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).......541$350
   Table 10: World Recent Past, Current and Future Analysis for Total Lab Automation by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......551$350
   Table 11: World Historic Review for Total Lab Automation by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......561$350
   Table 12: World 15-Year Perspective for Total Lab Automation by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).......571$350
   A. Market Analysis.......58
Current & Future Analysis.......58
Automation Industry: At a Glance.......58
Major Drivers of Lab Automation Market.......58
Regulations Dictate Technological Changes in Laboratories.......58
1$100
   Product Launches.......594$400
   Strategic Corporate Developments.......635$350
   Focus on Select Major Players.......685$350
   B. Market Analytics.......73
Table 13: US Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand- alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......73
1$350
   Table 14: US Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......74

Table 15: US 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).......74
1$350
   A. Market Analysis.......75
Current & Future Analysis.......75
European Clinical Diagnostics Automation Market: A Prelude.......75
1$100
   Economic Factors – Key Drivers to Growth.......76
Manufacturers Face Significant Challenges.......76
Future Trends.......76
1$100
   Automation Supports Growth in West European IVD Market.......77
Product Launches.......77
1$100
   Strategic Corporate Developments.......784$400
   Focus on Select European Players.......822$200
   B. Market Analytics.......84
Table 16: European Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......84
1$350
   Table 17: European Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......851$350
   Table 18: European 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......861$350
   Table 19: European Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region – France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......871$350
   Table 20: European Historic Review for Clinical Diagnostics Automation by Geographic Region – France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......88

Table 21: European 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2003, 2010 and 2015 (includes corresponding Graph/Chart).......88
1$350
   A. Market Analysis.......89
Current & Future Analysis.......89
Product Launches.......89
2$200
   B. Market Analytics.......91
Table 22: French Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......91
1$350
   Table 23: French Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......92

Table 24: French 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......92
1$350
   A. Market Analysis.......93
Current & Future Analysis.......93
Strategic Corporate Development.......93
1$100
   B. Market Analytics.......94
Table 25: German Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......94
1$350
   Table 26: German Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......95

Table 27: German 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......95
1$350
   Market Analysis.......96
Table 28: Italian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......96
1$350
   Table 29: Italian Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......97

Table 30: Italian 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......97
1$350
   A. Market Analysis.......98
Current & Future Analysis.......98
B. Market Analytics.......98
Table 31: UK Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......98
1$350
   Table 32: UK Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......99

Table 33: UK 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......99
1$350
   A. Market Analysis.......100
Current & Future Analysis.......100
B. Market Analytics.......100
Table 34: Spanish Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......100
1$350
   Table 35: Spanish Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......101

Table 36: Spanish 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......101
1$350
   A. Market Analysis.......102
Current & Future Analysis.......102
B. Market Analytics.......102
Table 37: Rest of Europe Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......102
1$350
   Table 38: Rest of Europe Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......1031$350
   Table 39: Rest of Europe 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......1041$350
   A. Market Analysis.......105
Current & Future Analysis.......105
Focus on Select Regional Markets.......105
Asia-Pacific.......105
India.......105
Automation of Clinical Laboratories On the Rise.......105
1$100
   Challenges Abound in the Indian Clinical Diagnostics Labs Market.......106
Diagnostics Arena Witnesses Rapid Transformation.......106
Private Enterprises Incite Changes in the Diagnostics Sector.......106
1$100
   Singapore.......107
Current & Future Outlook.......107
Japan.......107
Automation – Past & Present.......107
Brazil.......107
Clinical Diagnostics Automation Market Poised to Grow.......107
1$100
   Table 40: Brazilian Clinical Diagnostics Automation Market (2010): Market Share Breakdown by Leading Companies – Siemens Healthcare, Abbott Diagnostics, Roche Diagnostics, and Others (includes corresponding Graph/Chart).......108
South Africa.......108
Laboratories Adopt Integrated Systems and Combined Workstations.......108
1$350
   Manufacturers’ Shifting focus on Ease of Use and Enhanced Automation Throughput.......109
Product Launches.......109
1$100
   Strategic Corporate Development.......1101$100
   B. Market Analytics.......111
Table 41: Rest of World Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).......111
1$350
   Table 42: Rest of World Historic Review for Clinical Diagnostics Automation by Product Segment – Automated Analyzers, Total Lab Automation, and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).......1121$350
   Table 43: Rest of World 15-Year Perspective for Clinical Diagnostics Automation by Product Segment – Percentage Breakdown of Dollar Sales for Automated Analyzers, Total Lab Automation, and Stand-alone Automation for Years 2003, 2010, and 2017 (includes corresponding Graph/Chart).......1131$350
  
Total Companies Profiled: 62 (including Divisions/Subsidiaries - 68)

Region/Country Players

The United States 40 Canada 3 Europe 22 France 3 Germany 4 The United Kingdom 6 Rest of Europe 9 Asia-Pacific (Excluding Japan) 3
Click here to request a full table of contents and more details on this project.